SUNLIGHT trial meets primary endpoint in refractory metastatic CRC Presented ByProf. Josep Tabernero, Val d’Hebron University Hospital and Institute of Oncology, Spain TrialPhase 3, SUNLIGHT ConferenceASCO GI 2023 17 March, 2023 08:45